A Change for Generics is on the Horizon

Get an inside view of changes affecting the biosimilars market and understand what they may mean for the near future of your business. Don’t miss your free eBook from Generics Bulletin, presented in partnership with West Pharmaceuticals, Inc.

Chapters in your free eBook include:

Samsung Bioepis Scoops First EU Lucentis Biosimilar As 2022 Date Looms
Samsung Bioepis Goes After Lucentis With 40% Cheaper Byooviz Launch In US
Coherus Shakes Up Ranibizumab Competition With First Interchangeable US Biosimilar
Formycon Wins Endorsement For Second EU Lucentis Rival
Stada And Xbrane Win EU Endorsement For Ranibizumab

Whitepaper

Complete the form below to download the content.

* - marks a required field

Email Address

First Name

Last Name

Address

City

Country

State

Post Code

Phone

Answer the following questions about your organization below:

Company Name

How many people are employed by your organization?

What is your company's revenue?

In which industry do you work?

Job Title

Job Level

By clicking ‘Submit’ you agree to our Terms of Use. We take your privacy seriously. For more information please read our Privacy Policy.